Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients

Clinical trial NCT05762900 · RECRUITING

Trial details

NCT number: NCT05762900
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Radiotherapy Side Effect

Start date: 2022-10-25
Primary completion: 2025-10-25
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.